- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Oncologic Outcomes in Young Adults With Kidney Cancer Treated During the Targeted Therapy Era.
February 6, 2020
The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.
February 6, 2020
PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas.
February 5, 2020
Replisome genes regulation by anti-tumor miR-101-5p in clear cell renal cell carcinoma.
February 5, 2020
miR-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
February 5, 2020
Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
February 4, 2020
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
February 4, 2020
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.
February 3, 2020
LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.
January 31, 2020
Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients.
January 30, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
January 30, 2020
Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition.
January 29, 2020